Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Current Deferred Revenue for 6 consecutive years, with $7.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 12.34% year-over-year to $7.5 million, compared with a TTM value of $7.5 million through Dec 2025, up 12.34%, and an annual FY2025 reading of $7.5 million, up 12.34% over the prior year.
  • Current Deferred Revenue was $7.5 million for Q4 2025 at Viemed Healthcare, down from $7.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $7.8 million in Q3 2025 and bottomed at $3.4 million in Q1 2021.
  • Average Current Deferred Revenue over 5 years is $5.5 million, with a median of $6.0 million recorded in 2023.
  • The sharpest move saw Current Deferred Revenue grew 0.82% in 2021, then soared 35.39% in 2023.
  • Year by year, Current Deferred Revenue stood at $3.8 million in 2021, then increased by 23.21% to $4.6 million in 2022, then skyrocketed by 34.23% to $6.2 million in 2023, then grew by 7.85% to $6.7 million in 2024, then rose by 12.34% to $7.5 million in 2025.
  • Business Quant data shows Current Deferred Revenue for VMD at $7.5 million in Q4 2025, $7.8 million in Q3 2025, and $7.2 million in Q2 2025.